Health Care·Life Sciences Tools & Services·$32.7B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.67 | N/A | +2.71% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.67 | N/A | +2.71% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed satisfaction with the EPS results, highlighting their commitment to innovation. They emphasized a focus on operational efficiency moving forward.
We are pleased with our EPS performance this quarter.
Our focus remains on driving innovation and efficiency.
Agilent Technologies reported a better-than-expected EPS for the quarter, which contributed to a 1.7% increase in stock price. However, the lack of revenue data and guidance leaves some uncertainty for investors. The positive EPS surprise suggests that the company is managing costs effectively, but future performance will depend on broader market conditions and operational strategies.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
INTUIT
Nov 20, 2017